Established in 2020, GT Diagnostics was founded as a collaboration between Genting Berhad, a Malaysian company, and TauRx Pharmaceuticals Ltd Group, with the vision to change the diagnostic landscape and market in dementia.
GT Diagnostics are leading the way in research for neurodegenerative disease. Lorem ipsum dolor sit amet, id quo elitr dolorum epicurei, eos audire regione legimus at. Iuvaret scribentur est ex, laudem doming perpetua eos an, at quas.
You can access a wide range of our resources – such as research papers, helpful guides, case studies, and more in our Resource Hub.
We have been committed to the development of tools that change a patient’s pathway in dementia and Alzheimer’s Disease for more than a decade.
Our mission is to provide the missing tools for early diagnosis and monitoring of disease progression in dementia; tools that can be used in the comfort of one’s home, to tools that require administration by experts.
Lorem ipsum dolor sit amet, id quo elitr dolorum epicurei, eos audire regione legimus at. Iuvaret scribentur est ex, laudem doming perpetua eos an, at quas oratio eam. Et suas eros malorum per. Ne recteque eloquentiam nam, pri et cetero tacimates. Quot augue recteque no vim, movet copiosae erroribus ut nam, civibus placerat vituperata in quo.
GT Diagnostics (UK) Limited
395 King Street
AB24 5RP
Aberdeen
United Kingdom
Genting TauRx Diagnostic Centre Sdn Bhd
14th Floor, Wisma Genting
Jalan Sultan Ismail
50250 Kuala Lumpur
Malaysia
